Keywords: erbitux, data, merck, presented, asco, imclone, systems

Erbitux data from Merck to be presented at ASCO

Article | 10 March 2003

ImClone Systems' European marketing partner for colorectal cancer drugErbitux (cetuximab), Germany's Merck KGaA, is scheduled to present the results of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Bristol-Myers Squibb

Go to company listing

Related Drugs

cetuximab

Erbitux

Go to drug listing